Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Current Pharmaceutical Design|February 18, 2004
Molecular therapy intervention prospects in prostate cancerYashraj D Rege, Vivek M RangnekarCurrent Drug Targets|March 20, 2003
Par-4 for molecular therapy of prostate cancerJames Butler, Vivek M RangnekarAnnals of the New York Academy of Sciences|December 31, 2005
Regulation of cancer cell survival by Par-4Padhma Ranganathan, Vivek M RangnekarJournal of Cellular Biochemistry|February 3, 2004
Par-4 inducible apoptosis in prostate cancer cellsSushma Gurumurthy, Vivek M RangnekarCancer Biology & Therapy|October 7, 2008
Apoptosis and tumor resistance conferred by Par-4Yanming Zhao, Vivek M RangnekarExperimental Cell Research|February 5, 2003
Apoptosis by Par-4 in cancer and neurodegenerative diseasesNadia El-Guendy, Vivek M RangnekarCancer Research|March 17, 2006
The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic targetAnindya Goswami, Padhma Ranganathan, Vivek M RangnekarJournal of Cellular Physiology|May 4, 2012
Mechanisms of apoptosis by the tumor suppressor Par-4Nikhil Hebbar, Chi Wang, Vivek M RangnekarCancer Cell|July 13, 2013
Par(-4)oxysm in breast cancerTripti Shrestha-Bhattarai, Nikhil Hebbar, Vivek M RangnekarMethods in Enzymology|June 8, 2006
Regulation of Par-4 by oncogenic RasKrishna Murthi Vasudevan, Padhma Ranganathan, Vivek M RangnekarPageof 7